Study identification

EU PAS number

EUPAS34604

Study ID

34605

Official title and acronym

ASSOCIATION BETWEEN THE USE OF DRUGS IN CHRONIC PAIN AND THE INCIDENCE AND SEVERITY OF COVID-19 INFECTION: A CASE-POPULATION STUDY (DC-COVID19)

DARWIN EU® study

No

Study countries

Spain

Study description

To assess if analgesic treatments and chronic pain have any impact on the prevalence and severity of COVID-19 infection through collecting population data from patients with confirmed COVID-19 with different evolution: admission requirement with only oxygen therapy support, admitted or emergency department with non-invasive ventilation requirement, admitted to Critical Unit with mechanical ventilatory support (supine, prone and ECMO) versus a control group of patients with chronic pain without COVID-19

Study status

Ongoing
Research institutions and networks

Institutions

Hospital Universitari de Bellvitge L'Hospitalet de Llobregat, Barcelona (Spain), Hospital U. La Princesa Madrid (spain), Complejo Hospitalario de Toledo Toledo (Spain), Hospital Comarcal L´Alt Penedes Barcelona (Spain), Hospital U y Politécnico La Fe de Valencia Valencia (Spain), Hospital Clínico Universitario Rio Ortega Valladolid (Spain), Hospital Clínico de Santiago de Compostela Santiago de Compostela (Spain), Hospital universitario de Ourense Ourense (Spain), Hospital General Universitario Santa Lucía Murcia (Spain), Hospital General U de Alicante Alicante (Spain)

Contact details

Victor Mayoral

Primary lead investigator
Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Data analysis start date

Planned:

Date of interim report, if expected

Planned:

Date of final study report

Planned:
Sources of funding
Other

More details on funding

own founds
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable